S'abonner

Supporting caregivers during hematopoietic cell transplantation for children with primary immunodeficiency disorders - 06/06/19

Doi : 10.1016/j.jaci.2018.10.017 
Jennie Yoo, BS a, Meghan C. Halley, PhD, MPH a, b, E. Anne Lown, DrPH c, Veronica Yank, MD d, Katherine Ort, MD a, Morton J. Cowan, MD e, Morna J. Dorsey, MD, MMSc e, Heather Smith f, Sumathi Iyengar, MD g, Christopher Scalchunes, MPA h, Christina Mangurian, MD, MAS a,
a Department of Psychiatry, Weill Institute for Neurosciences, San Francisco, Calif 
c Department of Social Behavioral Sciences, San Francisco, Calif 
d Department of General Internal Medicine, University of California, San Francisco, Calif 
b Palo Alto Medical Foundation Research, Palo Alto, Calif 
e Benioff Children's Hospital, Pediatric Allergy, Immunology, Blood and Marrow Transplant Division, University of California, San Francisco, Calif 
f SCID, Angels for Life Foundation, Lakeland, Calif 
g Wiskott-Aldrich Foundation, Smyrna, Ga 
h Immune Deficiency Foundation, Towson, Md 

Corresponding author: Christina Mangurian, MD, MAS, Department of Clinical Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Institute for Neurosciences, San Francisco General Hospital, 1001 Portero Ave, Suite 7M, San Francisco, CA 94110.Department of Clinical PsychiatryUniversity of California, San Francisco, and the Department of PsychiatryWeill Institute for NeurosciencesSan Francisco General Hospital1001 Portero Ave, Suite 7MSan FranciscoCA94110

Abstract

Background

Caregivers of children with primary immunodeficiency disorders (PIDs) experience significant psychological distress during their child's hematopoietic cell transplantation (HCT) process.

Objectives

This study aims to understand caregiver challenges and identify areas for health care system-level improvements to enhance caregiver well-being.

Methods

In this mixed-methods study caregivers of children with PIDs were contacted in August to November 2017 through online and electronic mailing lists of rare disease consortiums and foundations. Caregivers were invited to participate in an online survey assessing sociodemographic variables, the child's medical characteristics, psychosocial support use, and the World Health Organization–5 Well-Being Index. Open-ended questions about health care system improvements were included. Descriptive statistics and linear multivariate regression analyses were conducted. A modified content analysis method was used to code responses and identify emergent themes.

Results

Among the 80 caregiver respondents, caregivers had a median age of 34 years (range, 23-62 years) and were predominantly female, white, and married with male children given a diagnosis of severe combined immune deficiency. In the adjusted regression model lower caregiver well-being was significantly associated with lower household income and medical complications. Challenges during HCT include maintaining relationships with partners and the child's healthy sibling or siblings, managing self-care, and coping with feelings of uncertainty. Caregivers suggested several organizational-level solutions to enhance psychosocial support, including respite services, online connections to other PID caregivers, and bedside mental health services.

Conclusions

Certain high-risk subpopulations of caregivers might need more targeted psychosocial support to reduce the long-term effect of the HCT experience on their well-being. Caregivers suggested several organizational-level solutions for provision of this support.

Le texte complet de cet article est disponible en PDF.

Key words : Hematopoietic cell transplantation, primary immune deficiency, caregiver, psychosocial support: well-being

Abbreviations used : HCT, PID, SCID


Plan


 Disclosure of potential conflict of interest: J. Yoo was supported by funding from UCSF's Resource Allocation Program for Trainees. V. Yank was supported by funding from the National Institutes of Health (NIH; K23DK097308). M. J. Cowan is supported by funding from the NIH (U54 AI 082973) and the California Institute of Regenerative Medicine (CLIN2-09504 and CLIN2-10830). M. J. Dorsey is supported by funding from the National Institute of General Medical Sciences (R01GM107132). C. Mangurian was supported by funding from the NIH (K23MH093689), as well as by funding from the UCSF John A. Watson Faculty Scholarship. The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 143 - N° 6

P. 2271-2278 - juin 2019 Retour au numéro
Article précédent Article précédent
  • Epigenetic age acceleration is associated with allergy and asthma in children in Project Viva
  • Cheng Peng, Andres Cardenas, Sheryl L. Rifas-Shiman, Marie-France Hivert, Diane R. Gold, Thomas A. Platts-Mills, Xihong Lin, Emily Oken, Lydiana Avila, Juan C. Celedón, Scott T. Weiss, Andrea A. Baccarelli, Augusto A. Litonjua, Dawn L. DeMeo
| Article suivant Article suivant
  • Nonatopic severe asthma might still be atopic: Sensitization toward Staphylococcus aureus enterotoxins
  • Jens Schreiber, Barbara M. Bröker, Rainer Ehmann, Claus Bachert

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.